A Study to Evaluate the Safety, Tolerability and How YH002 Enters, Moves Through and Exits the Body in Subjects With Advanced Solid Malignancies
Clinical trial NCT04353102 · COMPLETED
Trial details
- NCT number
- NCT04353102
- Sponsor
- Eucure (Beijing) Biopharma Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-22
- Primary completion
- 2021-09-14
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.